Table 7.
Serious adverse events possibly related to study treatment
| Treatment group | Adverse event | Grade | Number of events |
| Cilengitide and gemcitabine | Myocardial infarction | 4 | 1 |
| Apoplexia | 4 | 1 | |
| Thrombocytopenia | 3 | 1 | |
| Exanthema | 1 | 1 | |
| Weakness | 3 | 2 | |
| Nausea | 3 | 1 | |
| Anaphylactic reaction | 4 | 1 | |
| Pulmonary embolism | 4 | 1 | |
| Gastrointestinal hemorrhage | 3 | 1 | |
| Hypotension1 | 3 | 1 | |
| Erysipelas1 | 3 | 1 | |
| Gemcitabine | Anorexia | 3 | 1 |
| Exanthema | 2 | 1 | |
| Depression | 3 | 1 | |
| Dyspnea | 3 | 2 | |
| Epistaxis | 2 | 1 | |
| Pneumonia | 2 | 1 | |
| Condition reduced1 | 3 | 1 |
1Relationship "not assessable" by investigator; therefore, considered to be possibly related.